Clinical and economic burden of major lower-limb amputations attributable to peripheral artery disease in Italy: A nationwide analysis

Peripheral artery disease (PAD) represents a major cause of non-traumatic lower-limb amputation and is associated with substantial morbidity, mortality, and healthcare costs. Despite advances in medical and revascularization therapies, major amputations remain frequent, and comprehensive nationwide estimates of their clinical and hospital-related economic burden within the Italian National Health Service (SSN) are limited. The objectives of this study were to estimate the hospital-related economic burden of major lower-limb amputations attributable to PAD in Italy and to assess revascularization patterns and in-hospital mortality within the SSN. We conducted a nationwide observational study using the Italian National Hospital Discharge Database. Acute hospital discharges between 2015 and 2021 with a major lower-limb amputation and Diagnosis Related Group 113 were identified. Inpatient volumes, length of stay, and costs were estimated by amputation level. A longitudinal cohort of patients amputated between 2015 and 2017 was followed for two years before and after the index hospitalization to assess prior revascularization and in-hospital mortality using age- and sex-adjusted Cox models. A total of 26,417 PAD-attributable major amputations were identified, 75.6% of which were above-knee procedures. Cumulative inpatient expenditure reached €294 million, corresponding to over 511,000 hospital days. Only 46.0% of patients underwent revascularization before amputation. In-hospital mortality increased steeply within the first six months post-amputation and remained higher after above-knee procedures and among patients with diabetes, reaching 16-25% at 180 days and 23-34% at two years. Major lower-limb amputation remains a severe and costly outcome of PAD in Italy. Improved implementation of guideline-recommended PAD management is needed to reduce avoidable amputations and their economic burden on the SSN.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-02
DOI
https://doi.org/10.1371/journal.pone.0361853
Primary Topic
Peripheral Artery Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical and economic burden of major lower-limb amputations attributable to peripheral artery disease in Italy: A nationwide analysis

Mauro Gargiulo, Marco Manzi, Paolo Sciattella, Luigi Uccioli et al.
2 links
PLoS ONE
Peripheral Artery Disease Management
article

Clinical and economic burden of major lower-limb amputations attributable to peripheral artery disease in Italy: A nationwide analysis

Mauro Gargiulo, Marco Manzi, Paolo Sciattella, Luigi Uccioli, Matteo Scortichini
article en

Abstract

Peripheral artery disease (PAD) represents a major cause of non-traumatic lower-limb amputation and is associated with substantial morbidity, mortality, and healthcare costs. Despite advances in medical and revascularization therapies, major amputations remain frequent, and comprehensive nationwide estimates of their clinical and hospital-related economic burden within the Italian National Health Service (SSN) are limited. The objectives of this study were to estimate the hospital-related economic burden of major lower-limb amputations attributable to PAD in Italy and to assess revascularization patterns and in-hospital mortality within the SSN. We conducted a nationwide observational study using the Italian National Hospital Discharge Database. Acute hospital discharges between 2015 and 2021 with a major lower-limb amputation and Diagnosis Related Group 113 were identified. Inpatient volumes, length of stay, and costs were estimated by amputation level. A longitudinal cohort of patients amputated between 2015 and 2017 was followed for two years before and after the index hospitalization to assess prior revascularization and in-hospital mortality using age- and sex-adjusted Cox models. A total of 26,417 PAD-attributable major amputations were identified, 75.6% of which were above-knee procedures. Cumulative inpatient expenditure reached €294 million, corresponding to over 511,000 hospital days. Only 46.0% of patients underwent revascularization before amputation. In-hospital mortality increased steeply within the first six months post-amputation and remained higher after above-knee procedures and among patients with diabetes, reaching 16-25% at 180 days and 23-34% at two years. Major lower-limb amputation remains a severe and costly outcome of PAD in Italy. Improved implementation of guideline-recommended PAD management is needed to reduce avoidable amputations and their economic burden on the SSN.

PLoS ONEVol. 21(11)
CTO Hospital (IT), University of Bologna (IT)
Good health and well-being
Openalex Percentile: Top 11%
Peripheral Artery Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon